{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-26-000063","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2026-09-10T10:00:47+00:00","discovered_at":"2026-09-10T10:05:00.506829+00:00","generated_at":"2026-09-10T10:05:22.479678+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Elevance reaffirms FY2026 EPS guidance: at least $20.10 GAAP, $27.00 adjusted","bullets":["Reaffirms FY2026 shareholders' EPS guidance of at least $20.10, including ~$6.90 net unfavorable items.","Excluding items, adjusted shareholders' EPS guidance at least $27.00 per diluted share.","Reaffirms FY2026 benefit expense ratio guidance of 90.2% ± 50 basis points.","Guidance reaffirmed during investor meetings over the next several weeks."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-26-000063","json":"https://secwatch.observer/filing/0001156039-26-000063.json","markdown":"https://secwatch.observer/filing/0001156039-26-000063.md","text":"https://secwatch.observer/filing/0001156039-26-000063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000063/0001156039-26-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000063/elv-20260910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-10T10:05:22.479678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}